Pharmaceutical Executive Europe - May 2008 - (Page 28)

28 Sales and Marketing May 2008 Pharmaceutical Executive Europe IC Success in Four Steps In the second of three IMS articles on precision compensation schemes, David Ziedman looks at best practice in the design of incentive compensation (IC) plans. Change driver — the market There are many different triggers being pulled in the market place prompting the need for IC planning today. The scenery is changing and pharmaco sales roles, organisational structures and key competences are changing with it. This has led to the emergence of a number of identifiable industry-wide initiatives, for example, customer relationship management (CRM); key account management (KAM); and team-based selling. These, in turn, are impacting on the design of tomorrow’s most effective IC plan. Some of these innovations, already apparent in other industries, place greater emphasis on the ‘softer side’ of sales: the strength and endurance of a relationship is now becoming at least as important, to some companies, as the volume of sales generated by a sales rep in the short term. This development alone affects the future desirable constructs of an IC plan and Figure 1 below illustrates how customer-centred/output criteria are beginning to replace — or stand alongside — the measurement of traditional activity/input based performance criteria within IC plans. The element of total remuneration driven by the achievement of these ‘soft’ objectives appears fairly consistent across European pharmacos, at around 4–8%. This is still only about half of that attributable to the attainment of ‘hard’ objectives such as sales targets. This suggests that a gulf remains between what might be theoretically desirable and the extent to which companies have adopted soft measures within their IC plans to-date. Most of the pharma companies surveyed earlier this year1 do, however, acknowledge that soft measures have a role to play in IC and that they should be looking to adopt them. Some, on the other hand, appear to have grown disillusioned with their use, finding them hard to apply or not useful in motivating sales in practice. Plainly there are challenges that have still to be overcome in this area – although typically companies did report they remained open to fresh ideas around increasing the proportion of bonus paid on achievement of ‘soft’ targets. Current plan not fit for purpose Beyond the change drivers apparent across the whole market referred to above, individual clients are reporting concerns that other flaws may be appearing in their current IC plan design. Amongst other business critical objectives, IC plans are designed to help deliver the strategy; ensure the successful launch of a vital new product, drive the right behaviours, reward high performance and retain talent. When they begin to lose their efficacy, this translates into higher costs (eg, due to higher than expected staff turnover) and/or lost sales revenues (eg, due to unforeseen vacancies in the sales force or a loss of motivation among stellar performers). A plan is typically designed to meet the objectives from a new product launch — to drive initial sales and penetration. Over time, as the product matures and as competitors or generics enter the market, companies may find that they need to re-focus away from incentivising top-line sales growth of this product to preserving their market share and staving-off competitors. The implication is that companies may therefore need to change how success is measured and what behaviours are rewarded by the plan. Figure 1: The shift to customer-centric selling will underpin IC plan.

Table of Contents for the Digital Edition of Pharmaceutical Executive Europe - May 2008

Pharmaceutical Executive Europe - May 2008
Contents
From the Editor
News and Analysis
Calendar
Rising in the East
Use Your Strategic Discretion
A Blueprint for Success
Market Access and the Patient
Activating Effective Product Differentiation
What Doctors Want
IC Success in Four Steps

Pharmaceutical Executive Europe - May 2008

http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201302
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201301
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201212
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201211
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201210
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201209
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201208
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201207
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201206
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201205
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201204
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201203
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201202
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201201
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201112
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201111
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201110
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201109
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110823
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110809
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110728_v2
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110728
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110711
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110624
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110609
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110526
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110512
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_oracle_201105
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110426
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110412
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110324
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110310
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110224
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110208
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110128
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_mediakit2011
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20101216
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20101124
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20101111
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20101027
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20101013
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100930
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100915_supp
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100915
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100825
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100811
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100727
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100713
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100623
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100609
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100526
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100512
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_ims_201005
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100427
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100414
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100324
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100310
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100224
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100210
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100126
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100112
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091222
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091208
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091124
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091110
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091027
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091013
http://digital.findpharma.com/nxtbooks/advanstaruk/PEE_DIGEST_20090930
http://digital.findpharma.com/nxtbooks/advanstaruk/PEE_digest_20090916
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090902
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090825
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090819
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090812
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090805
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090729
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090721
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090715
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090708
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090701
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090624
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090617
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090610
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090602
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090526
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090519
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090512
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090505
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_southafrica
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090429
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090422
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090415
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090408
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090401_v2
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090401
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090325
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090318
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090311
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090304
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090224
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090218
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090211
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090203
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090128
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090121
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090114
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1208
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1108
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1008
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-ims1008
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0908
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0808
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0708
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0608
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imssales0508
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0508
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0408
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0308
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0208
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imssales0208
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0108
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-ims1207
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1107
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1007
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imsoncology0907
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0407
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0307
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1206
https://www.nxtbookmedia.com